Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Clinical trial NCT03297398 · TERMINATED
Trial details
- NCT number
- NCT03297398
- Sponsor
- OPKO Health, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2019-04-18
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.